UAB REACT aims to catalyze high-impact clinical trials in medical rehabilitation. CAMBAC members Drs. Bamman, Bridges, Saag, McGwin, McLain, Standaert, Cutter and Curtis are members of the REACT Center Executive Leadership team. Click here for information
UAB Rheumatology Insight
“To get the immune system to respond to the vaccine, you have to think about its response to the adapted form of HIV, and focus on those parts of the virus that are most difficult to undergo adaptation”, says Paul Goepfert, MD, member of CAMBAC. More
An $1.8 million Department of Defense grant just awarded to S. Louis Bridges, JR, MD, PhD and Chander Raman, Ph.D., to uncover molecular changes explaining how rheumatoid arthritis leads to joint damage. For details, click here.
UAB researchers, led by CAMBAC member David Standaert, M.D., Ph.D., professor and chair of the UAB Department of Neurology, show that a microRNA is involved in early Parkinson’s disease pathogenesis. Click here for more